Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

June 12, 2013
Bioniche Founder and CEO Addresses Shareholders

June 5, 2013
Paladin Labs Inc. and Bioniche Life Sciences Inc. Sign Debt Refinancing and Urocidin™ Licensing Deals

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.


Shareholder Information

Inquiries related to stock transfer, lost certificates or address changes should be directed to our Transfer Agent, CIBC Mellon Trust Company.

Contact information:

CIBC Mellon Trust Company
c/o Canadian Stock Transfer Company Inc.
P.O. Box 700, Station B
Montreal, QC, H3B 3K3
Tel: 1 (800) 387-0825 / (416) 682-3860
Fax: 1 (888) 249-6189
E-mail: inquiries@canstockta.com
Website: www.canstockta.com

Bioniche financial reports can be downloaded here

 

Request investor materials by regular mail here

All Bioniche publicly-listed documents can be viewed here

E-mail Alerts

To automatically receive an e-mail alert when Bioniche news releases are posted to this site, enter your e-mail address here.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy